Extra opportunities for young cancer researchers

(17-03-2023) Cancer researcher Celine Everaert is currently developing an important test that should help to improve treatment for cancer patients. This is possible because of a scholarship, funded by donations and bequests.

The blood test that professor Celine Everaert is developing determines who will benefit from immunotherapy and who won’t. Indeed, the therapy does not work equally on everyone: for three out of ten lung-cancer patients, for example, the most common type of treatment is unsuccessful.

The test can make a big difference in determining the proper treatment. “We want to match each patient with the correct medicine”, explains Celine. “So we don’t lose precious time, and we can improve and target the treatment better. We call this precision medicine.”